Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slfn2 Inhibitors

Slfn2 inhibitors belong to a specialized category of chemical compounds that specifically target and inhibit the activity of Schlafen family member 2 (Slfn2), a protein encoded by the SLFN2 gene. This protein plays a crucial role in various cellular processes, and its inhibition by these compounds can lead to significant alterations in cell behavior. The chemical structure of Slfn2 inhibitors is typically characterized by a high degree of specificity and affinity towards the Slfn2 protein, allowing them to bind effectively and block its activity. These inhibitors are designed to interact with key domains of the Slfn2 protein, often targeting its active sites or regions critical for its structural integrity or interaction with other cellular components.

The development and study of Slfn2 inhibitors involve advanced chemical synthesis and molecular biology techniques. Researchers focus on understanding the molecular interactions between these inhibitors and the Slfn2 protein at a detailed level, often employing techniques such as X-ray crystallography, NMR spectroscopy, and computational modeling. These studies are crucial for refining the inhibitors' design, enhancing their specificity and potency. The molecular structure of Slfn2 inhibitors often includes a variety of functional groups and moieties, which are strategically placed to optimize binding to the Slfn2 protein. These functional groups may include, but are not limited to, aromatic rings, heteroatoms, and hydrogen bond donors or acceptors. The physicochemical properties of these inhibitors, such as solubility, stability, and molecular weight, are also carefully considered during their development, as these factors can significantly impact their interactions with the Slfn2 protein and overall behavior in a cellular context.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin forms a complex with FKBP12 that inhibits mTOR, a kinase involved in protein synthesis, possibly reducing Slfn2 expression.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, which could indirectly reduce Slfn2 expression.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, potentially impacting proteins involved in Slfn2 regulation.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A binds to DNA and preferentially inhibits transcription of GC-rich templates, which may include the Slfn2 gene.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin inhibits Topoisomerase I, leading to DNA damage and potentially affecting Slfn2 transcription.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Mitomycin C cross-links DNA upon reductive activation, which could hinder Slfn2 gene transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D binds to DNA and inhibits transcription elongation by RNA polymerase, which could reduce Slfn2 mRNA synthesis.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases and might affect cell cycle-related expression of Slfn2.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

JQ1 inhibits BET bromodomain proteins, affecting transcriptional elongation and potentially decreasing Slfn2 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor that may alter transcription factor activity, possibly reducing Slfn2 expression.